The URL can be used to link to this page

Home My WebLink About021225 - Changing the story of Merkel cell carcinomaALERT: BE CAUTIOUS This email originated outside the organization. Do not open attachments or click on links if you are not expecting them. Aggressive skin cancer | Smith Family endowed chair | Reducing chronic GVHD ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ View as Web page <https://secure.fredhutch.org/site/R?i=YgyC3Y9URugn_VfQ_KOqA1RHmD1z26ZUTvsRGBgnMNmYwPZ6dNUi0w> <https://secure.fredhutch.org/site/R?i=E-IgWgxbUSC2e0w8X7krbRK7OzR0dY-Vkye7_WFRHd2AK2y4-uiW5g> <https://secure.fredhutch.org/images/content/pagebuilder/fhcc-eml-hdr-shadow.png> <https://secure.fredhutch.org/images/content/pagebuilder/hdr-eml-hutch-news-fhcc.jpg> February 12, 2025 ⋅ A monthly digest of the latest from Fred Hutch Nghiem Lab and its supporters improve outcomes for patients with a rare cancer <https://secure.fredhutch.org/site/R?i=174EYPydpq8KnnXykNrROhfhDRjBIpZUuCg5d_8lmDQFrYQGcVsZEw> Merkel cell carcinoma, or MCC, is so rare that newly diagnosed patients are often the first case their oncologist has ever treated. For many patients, understanding this aggressive skin cancer’s prognosis and treatment begins online, quickly leading to merkelcell.org — and the visionary team behind it. Over the past two decades, Paul Nghiem, MD, PhD, and the Nghiem Lab have championed innovations in MCC treatment, delivering new treatment options, setting ever-higher standards of care and improving outcomes for MCC patients worldwide. And behind each breakthrough? A dedicated — and growing — community of supporters whose generosity fuels this progress. Moving MCC research forward <https://secure.fredhutch.org/site/R?i=fbBgVt0fHbFbv6JlfnVRokfgQI8QkNmcWNyEgW5fh_d3Z_YB4ZrYIA> . ________________________________ Join the Campaign for Fred Hutch <https://secure.fredhutch.org/site/R?i=ImaPlj408u6TXm4BZzPqDyEUNTJEYmKe1jBhrtUk3uevhR3rLkJQMA> As we mark our 50th anniversary in 2025, Fred Hutch is looking beyond what’s possible today to a new era of discovery. We invite you to learn more about our Campaign for Fred Hutch <https://secure.fr edhutch.org/site/R?i=5nifVCWBE1Abq2c0_3PMm4kb5sBTUb6kh0WOkl_1HXt6-Pf7Xb0Q4Q> , and how together, we will transform the pace and scale of innovation in cancer and infectious disease research. ________________________________ The Latest Hurvitz receives the Smith Family Endowed Chair <https://secure.fredhutch.org/site/R?i=VIg3IRIyz4uS-xQiHyvCOTRLOmCM-_z0VxE3x9Hpetau4mkRose9-Q> Fred Hutch Senior Vice President and Director of the Clinical Research Division Sara Hurvitz, MD, recently received the inaugural Smith Family Endowed Chair in Women’s Health. The new endowed chair will provide an enduring source of flexible funding to help fuel efforts to improve survivorship and quality of life for women with cancer. King named a Hanna Gray Fellow <https://secure.fredhutch.org/site/R?i=0ZJoeij2iKZQugUR6bjXTyiuS5KYhLJXH12VbT7dHLk_dN5I1gu9PQ> The Howard Hughes Medical Institute named Grant King, PhD, a Hanna H. Gray Fellow — investing up to $1.5 million for up to eight years to help King achieve his goal of running his own lab. He is among 25 selected in the newest cohort of the prestigious fellowship, which was established in 2016 to support early career scientists. Novel regimen greatly reduced chronic GVHD <https://secure.fredhutch.org/site/R?i=7vLCfpvhu-X3UGSfHkv0vHGZnb9tzP78Qw54mfRX2DBEARvhpzvsBA> Chronic graft-vs.-host disease (cGVHD) can be debilitating for people who have had an allogeneic stem cell transplant. In GVHD, the transplanted donor cells recognize the recipient’s tissues as foreign and attack them. A novel drug regimen tested for the first time by researchers at Fred Hutch has shown great promise in preventing moderate to severe cGVHD. Cold air makes oxygen toxic for worms <https://secure.fredhutch.org/site/R?i=1H59XKaPb_4yjSv6ATQ6T-ODXUumVQEVeX34LJpSey0hyGMs5W3cuw> Fred Hutch study shows C. elegans, a microscopic worm, can survive low temperatures if oxygen supply is also low. The research is part of a larger effort to see how “suspended animation” could be beneficial to humans in some medical scenarios. Oncology Insights for providers <https://secure.fredhutch.org/site/R?i=py4zXTEKxx_QaHLKiWlfveU95irhy49C8DCKwSalafVuNT9hFKW2Dw> Cancer treatment and research breakthroughs require a team effort. We have refreshed our Oncology Insights to provide more tools and expertise for the physicians and care providers delivering world-class treatment for patients living with cancer. ________________________________ Check out our Legacy Toolkit! As we celebrate the progress we've made in our first 50 years, we hope you will consider what your legacy will be. By choosing to include a gift in your estate plans for Fred Hutch, you will help increase the pace and scale of our work to redefine cancer and infectious disease for generations to come. You will also join a group of caring individuals who are members of the Thomas Legacy Society <https://secure.fredhutch.org/site/R?i=54tPxd7pAv4WgBpA-Fxk1ed9XkFQjInYJbsgWXNXSDgxsBtYNgfMJw> . Visit our Legacy Toolkit for more information. <https://secure.fredhutch.org/site/R?i=GKzxUcwBWiWYUZPdVMYyGrXfEQAHHkJRt2qCkvPVXeqRg0Fqbmc7IQ> ________________________________ Share this newsletter with family or friends <https://secure.fredhutch.org/site/R?i=qt8PHOMmI05HvIPPSqRu-i7JOqi0IzBuksukK7twIH-UxBUd-z8Ufw> <https://secure.fredhutch.org/site/R?i=BsoXtydrM_VPek292jAaiimT7H0orJPRHdBvXXQiof4fp-vK7m6O0w> 1100 Fairview Ave. N., Seattle, WA 98109 communications@fredhutch.org <mailto:communications@fredhutch.org> 206.667.5000 <https://secure.fredhutch.org/site/R?i=rqUB2lCZzaDN9INZX2WQEHcFGqh8s4tiCi5YdmWOkDCINJZ5uVgXVQ> <https://secure.fredhutch.org/site/R?i=Dpq5Ww2Fb9lZR9VjHMvs8UrxYtlTKPP4gu1OCS6tHrXiY56b4ktqLw> <https://secure.fredhutch.org/site/R?i=P9KseEcpITxq12-5MgUYlMU3fpxAP7tfAbUc_Ln88T4eYcDd1X7XxQ> <https://secure.fredhutch.org/site/R?i=S79EOj16Sz1nr2QxkzDdPsG4cfnUvw3ju8RgsgYo95jjjiOBgD2K3w> ________________________________ Unsubscribe <http://engage.fredhutch.org/site/CO?i=5VOhbx83W0z0KfnWeNu23m2cH1tE6kOypgewjKNG9lJYajXU5Xl7tehS4-chdXvM&cid=1021> from Fred Hutch emails or contact us at optout@fredhutch.org <mailto:optout@fredhutch.org> to be removed from our mailing list. Fred Hutchinson Cancer Center is a 501(c)(3) nonprofit organization. For information about our privacy practices, see our Privacy Policy <https://secure.fredhutch.org/site/R?i=rWhigozAQYh7lUYnydc2o88IadnOrsIsEP4-GkfNLvjdQ5kycFnjtw> . © 2025 Fred Hutchinson Cancer Center. All rights reserved. <http://engage.fredhutch.org/site/PixelServer?j=gYD6MoTvgygDZcNTgPDb8uuPyFkCv88aAbFRd4_iWwQPLqPRJOWpkw>